| Firm |
Analyst |
| Barclays |
Balaji Prasad |
| BMO Capital Markets |
Gary Nachman |
| Cowen and Company |
Ken Cacciatore |
| Goldman Sachs |
Nate Rich |
| Guggenheim |
Dana Flanders |
| J. P. Morgan |
Chris Schott |
| Morgan Stanley |
David Risinger |
| Piper Sandler |
David Amsellem |
| Raymond James |
Elliot Wilbur |
| RBC Capital Markets |
Randall Stanicky |
| Truist Securities |
Gregg Gilbert |
Amneal Pharmaceuticals ("Amneal") is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Amneal's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Amneal or its management. Amneal does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.